Philips demonstrates strong climate governance with SBTi-validated targets, 80% renewable energy, and A-list CDP scores across 11 years. However, operational emissions rose 5.81% in 2024, Scope 3 remains 537% above 2018 levels, and a massive product safety recall with ongoing DOJ/SEC scrutiny severely undermines credibility.
Same formula for every company. No curve. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleStrongest on Carbon Footprint — Operations and Transparency & Accountability (8/10, 8/10). Weakest on Controversies & Red Flags and Nature & Biodiversity Impact (4/10, 5/10).
18 sources used in this assessment. All publicly available. Each row shows which rubric questions it informed.
12 of 18 sources are third-party verified or public record.
If you believe a source has been misread or a newer version exists, submit a challenge.
Among the 11 major healthcare / pharmaceuticals brands we've scored, Royal Philips is tied =6th of 11, with 1 other.
Score history begins 11 April 2026.
As Royal Philips's score updates, the trajectory will appear here.
We're backfilling historical scores for FTSE 100 and S&P 100 companies over the coming weeks.
Every challenge is published. We'd rather be corrected than wrong — that's the whole point.
No challenges submitted yet. If you have evidence that contradicts this score, you can challenge any question above — cite a public source and we'll review it.
Royal Philips is a Dutch healthcare and electronics conglomerate founded in 1891, headquartered in Amsterdam. The company manufactures medical devices, diagnostic imaging systems, patient monitoring equipment, and consumer health products. With 81,592 employees and €17.2 billion annual revenue, Philips ranks among Europe's largest diversified industrial manufacturers.
Large diversified industrial conglomerate with parallel climate targets and product safety audit challenges.
View breakdown →Healthcare and industrial equipment manufacturer; comparable scale and regulatory scrutiny in medical device domains.
View breakdown →Major healthcare multinational with extensive ESG reporting and ongoing product liability litigation legacy.
View breakdown →Swiss pharmaceutical and diagnostics peer; comparable SBTi commitments and supply-chain carbon transparency standards.
View breakdown →Email alerts when a rubric question is verified, a challenge is resolved, or the overall score changes.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Readers and institutions support our work. Companies can pay to submit evidence we couldn't find. Neither type of payment changes a score.